Inhibition of heparin precipitation, bacterial growth, and fungal growth with a combined isopropanol-ethanol locking solution for vascular access devices

Journal of Pediatric Surgery
Daniel RestrepoMark L Kayton

Abstract

Clinical reports of ethanol-lock use for the prevention of catheter-related bloodstream infections have been marked by the occurrence of serious catheter occlusions, particularly among children with mediports. We hypothesized that precipitate forms when ethanol mixes with heparin at the concentrations relevant for vascular access devices, but that the use of a combination of two alcohols, ethanol and isopropanol, would diminish heparin-related precipitation, while retaining anti-bacterial and anti-fungal effects. Heparin (0-100units/mL) was incubated in ethanol-water solutions (30%-70% vol/vol) or in an aqueous solution containing equal parts (35% and 35% vol/vol) of isopropanol and ethanol. Precipitation at temperatures from 4 to 40°C was measured in nephelometric turbidity units using a benchtop turbidimeter. Growth of Escherichia coli, Staphylococcus aureus, and Candida albicans colonies were measured following exposure to solutions of ethanol or isopropanol-ethanol. Groupwise comparisons were performed using analysis of variance with Bonferroni-corrected, post-hoc T-testing. Seventy percent ethanol and heparin exhibit dose-dependent precipitation that is pronounced and significant at the concentrations typically used in med...Continue Reading

References

May 1, 1989·The American Journal of Emergency Medicine·M P Gaudet, G L Fraser
Dec 13, 1965·JAMA : the Journal of the American Medical Association·W E WackerJ E Coleman
Jan 1, 1996·Archives of Oral Biology·C H SissonsT W Cutress
Aug 31, 2000·Pediatric Emergency Care·E Stremski, H Hennes
Sep 23, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·A SimonM H Kramer
Aug 7, 2003·Journal of Pediatric Hematology/oncology·Claudia DannenbergDieter Körholz
Sep 15, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Christopher J CrnichDennis G Maki
Oct 5, 2006·Archives of Pediatrics & Adolescent Medicine·Wes OnlandWing-Yen Wong
Feb 3, 2007·The New England Journal of Medicine·Ashkan Emadi, LeAnn Coberly
Nov 22, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Mary Petrea Cober, Cary E Johnson
Nov 30, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Jeffrey A Kraut, Ira Kurtz
Jan 30, 2010·Journal of Emergency Nursing : JEN : Official Publication of the Emergency Department Nurses Association·Jason D Clark
Apr 8, 2010·The Journal of Surgical Research·Michelle J Henry-StanleyDonavon J Hess
Oct 21, 2010·JPEN. Journal of Parenteral and Enteral Nutrition·M Petrea CoberDaniel H Teitelbaum
Oct 20, 2011·Journal of Pediatric Surgery·Eunice Y HuangUNKNOWN 2011 American Pediatric Surgical Association Outcomes and Clinical Trials Committee

❮ Previous
Next ❯

Citations

Jan 7, 2016·JPEN. Journal of Parenteral and Enteral Nutrition·Ethan A MezoffConrad R Cole
Feb 22, 2017·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Leah Molloy
Aug 3, 2017·JPEN. Journal of Parenteral and Enteral Nutrition·Riad RahhalConrad R Cole
Dec 17, 2019·Pediatrics International : Official Journal of the Japan Pediatric Society·Masahiro ChibaAkira Toki
Jan 14, 2017·Asia-Pacific Journal of Oncology Nursing·Laurl Matey, Dawn Camp-Sorrell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.